Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptide Identification Using Tandem Mass Spectrometry01:33

Peptide Identification Using Tandem Mass Spectrometry

6.4K
Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of mental illness in Northern Territory prisoners.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2026
Same author

Concurrent Vulvar and Cutaneous Melanoma in a 40-Year-Old Woman: A Rare Case of Multiple Primary Melanomas.

Gynecologic oncology reports·2026
Same author

Detection of Zwan-Wolf effect in the ionosphere of Mars.

Nature communications·2026
Same author

Pastoral care and unmet need in acute mental health services.

Lancet (London, England)·2026
Same author

Multi-site DMS probing reveals higher-order structure of RNA-protein complexes in living cells.

Molecular cell·2026
Same author

Public Metabolic Bariatric Surgery in Adults With Obesity and Diabetes: 2-Year Safety, Weight and Diabetes Outcomes.

ANZ journal of surgery·2026
Same journal

Advancing microalgae biomass cultivation for an integrated sustainable wastewater treatment and resource recovery.

iScience·2026
Same journal

Corrigendum to "Human adipose ECM alleviates radiation-induced skin fibrosis via endothelial cell-mediated M2 macrophage polarization" [iScience, Volume 26, Issue 9 (2023) 107660].

iScience·2026
Same journal

High-definition transcranial direct current stimulation enhances exercise-induced hypoalgesia in patients with chronic low back pain.

iScience·2026
Same journal

From pre-tumor to tumor: Decoding the endoscopic-pathologic spectrum of neoplastic lesions in autoimmune gastritis.

iScience·2026
Same journal

Corrigendum to "A cobalt-aluminium layered double hydroxide with a nickel core-shell structure nanocomposite for supercapacitor applications" [iScience, 28 (2025) 111672].

iScience·2026
Same journal

Repurposing primaquine diphosphate for imatinib-resistant chronic myeloid leukemia via targeting BCR-ABL and Wnt/β-catenin pathway.

iScience·2026
See all related articles

Related Experiment Video

Updated: Jul 1, 2025

Cell-Lineage Guided Mass Spectrometry Proteomics in the Developing Frog Embryo
09:18

Cell-Lineage Guided Mass Spectrometry Proteomics in the Developing Frog Embryo

Published on: April 21, 2022

1.7K

ProteoMixture: A cell type deconvolution tool for bulk tissue proteomic data.

Pang-Ning Teng1,2, Joshua P Schaaf1,2, Tamara Abulez1,2

  • 1Gynecologic Cancer Center of Excellence and the Women's Health Integrated Research Center, Annandale, VA 22003, USA.

Iscience
|March 5, 2024
PubMed
Summary
This summary is machine-generated.

This study shows that protein data can accurately estimate cancer cell admixture, similar to gene expression data. Optimized protein signatures are now available for researchers to analyze bulk tumor proteomic data.

Keywords:
Computational bioinformaticsProteomicsTranscriptomics

More Related Videos

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

568
Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
10:37

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

12.0K

Related Experiment Videos

Last Updated: Jul 1, 2025

Cell-Lineage Guided Mass Spectrometry Proteomics in the Developing Frog Embryo
09:18

Cell-Lineage Guided Mass Spectrometry Proteomics in the Developing Frog Embryo

Published on: April 21, 2022

1.7K
A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

568
Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
10:37

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

12.0K

Area of Science:

  • Cancer Research
  • Proteomics
  • Transcriptomics
  • Bioinformatics

Background:

  • Multi-omic studies reveal poor correlation between transcript and protein levels in cancer tissues.
  • Existing cell admixture deconvolution tools primarily rely on transcriptomic data.
  • Accurate estimation of cell type proportions (cell admixture) is crucial for understanding tumor microenvironment heterogeneity.

Purpose of the Study:

  • To evaluate the utility of protein abundance data for estimating cell admixture in cancer.
  • To develop and optimize protein-based signatures for cell type proportion estimation.
  • To benchmark these protein signatures using bulk tumor proteomic data from high-grade serous ovarian cancer (HGSOC) patients.

Main Methods:

  • Analysis of proteome and transcriptome data from contrived cell admixtures (tumor, stroma, immune cells).
  • Utilized laser microdissection to harvest cells from HGSOC tumor microenvironments.
  • Applied two deconvolution algorithms (ESTIMATE, ConsensusTME) using co-quantified transcript and protein data.
  • Developed and validated protein-based signatures for cell admixture estimation.

Main Results:

  • Co-quantified transcripts and proteins demonstrated comparable performance (r ≥ 0.63) in estimating stroma and immune cell admixture using standard deconvolution algorithms.
  • Optimized protein signatures effectively estimated cell admixture proportions from bulk tumor proteomic data.
  • Benchmarking was performed on proteomic data from over 150 HGSOC patients.

Conclusions:

  • Protein abundance data is a viable and effective alternative to transcriptomic data for estimating cell admixture in cancer.
  • Developed protein signatures provide a valuable resource for deconvolution analysis of bulk tumor proteomic datasets.
  • These findings facilitate a deeper understanding of tumor microenvironment composition using proteomic approaches.